Product Information

QUETIAPINE FUMARATE 200 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0937 per EA under NDC 67877024601. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Feb 12, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 200 MG TAB

Quetiapine
$0.0937per EA

Strength

200 mg/1

NDC

67877024601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201504

FDA Approved

2/12/2013

TE Code

AB

On Market Since

3/1/2013

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 200 MG TAB has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0937 per EA
All-time high$0.3373 (Mar 12, 2014)
All-time low$0.0790 (Nov 20, 2024)
52-week high$0.0937
52-week low$0.0845
Median price$0.1265
Average price$0.1561
Largest weekly change+32.4% (Jun 19, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+4.5%

3M

+9.6%

6M

+7.4%

1Y

+1.1%

3Y

-12.3%

5Y

-21.1%

All

-71.8%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 200 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 200 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.0937 per EA (NDC 67877024601), effective Nov 11, 2026.

How has the price of QUETIAPINE FUMARATE 200 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 200 MG TAB has declined 71.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 200 MG TAB?

Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 200 MG TAB has ranged from a low of $0.0790 (Nov 20, 2024) to a high of $0.3373 (Mar 12, 2014), with a median of $0.1265 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 200 MG TAB?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 200 MG TAB, is $0.0882 per EA — about 6% below QUETIAPINE FUMARATE 200 MG TAB.

Who manufactures QUETIAPINE FUMARATE 200 MG TAB?

QUETIAPINE FUMARATE 200 MG TAB (NDC 67877024601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.